Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.

NCT04721821 · clinicaltrials.gov ↗
COMPLETED
Status
7807
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer